The previous literature has reported a correlation between NTMT1 and the development of AML, LIHC, and CESC (Yankova & Blackaby, 2021; Zhang & Song, 2021; Pan & Lin, 2021; Campeanu & Jiang, 2021; Tooley & Catlin, 2023). Here, NTMT1 is linked to acute myeloid leukemia.